This session, chaired by Professor Kwee Yong from University College Hospital, will focus on new research in blood cancer, with particular emphasis on the results of practice-changing findings presented recently at ASCO and EHA. Specifically, speakers will focus on Acute Lymphoblastic Leukaemia (ALL), Acute Myeloid Leukaemia (AML) and myeloma, and will discuss the impact and influence of these studies on UK practice. There will be an opportunity for attendees to submit questions live.
- Dr Rakesh Popat – University College Hospital
- Professor Charles Craddock – University of Birmingham
- Dr Tobias Menne – Northern Centre for Cancer Care
1 category 1 (external) CPD for this session has been approved by the Federation of the Royal Colleges of Physicians. CPD Certificates will be sent to delegates automatically up to 10 days after the event date.
Who should attend?
Scientists, medical/clinical oncologists, surgeons, early career researchers, nurses, allied health professionals, PhD and undergraduate students, research teams, research managers/funders, patient experts and carers formally involved in research.